Ins and Outs

March 3rd, 2009 News

  • TARGET REGLAN: FDA Requires Boxed Warning and Risk Mitigation Strategy for Metoclopramide-Containing Drugs… [FDA]
  • NEWSWEEK UNLOADS: Why Doctors Hate Science… [Newsweek]
  • Harvard Medical School in Ethics Quandary… [NYT]
  • Medtronic to Voluntarily Disclose Payments to U.S. Physicians… [Medtronic]
  • Falsified data gets India’s largest generic drug-maker into trouble… [Nature]
  • A Macaque Model of HIV Infection… [HHMI]
  • Obama Will Move to Rescind ‘Conscience’ Rule on Abortion, Birth Control … [WSJ]
  • Good or Useless, Medical Scans Cost the Same… [NYT]
  • Genzyme Shows Biotech Drugs Are Tough to Reproduce … [WSJ]
  • Boston Scientific Announces Japanese Launch of Taxus® Liberte® Drug-Eluting Stent System… [Boston Scientific]
  • Scientists Find Evidence for Precise Communication Across Brain Areas During Sleep… [Caltech]
  • Reinforcing Kevlar with carbon nanotubes… [Nanowerk]
  • Improved nanotechnology implants through nanopatterned metal surfaces… [Nanowerk]
  • TV viewing before the age of 2 has no cognitive benefit, study finds… [Children’s Hospital Boston]
  • The Wisdom on Wisdom Teeth… [MSN]

    • Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

    © Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.